Vripreg-M Plus Tablet SR
Marketer
Vridam Healthcare Pvt Ltd
Salt Composition
Methylcobalamin (1500mcg) + Pregabalin (75mg)
Overview Vripreg-M Plus Tablet SR
Combirelief-NP Extended-Release Tablets are a prescription medication managing neuropathic pain. Its mechanism involves regulating calcium channel function within nerve cells, thus reducing pain signals. This medication also supports nerve fiber health and promotes the repair of damaged nerve cells. Combirelief-NP Extended-Release Tablets are taken orally, with or without food, ideally before sleep. Consistent daily timing helps maintain stable drug levels. Follow your physician's prescribed dosage and duration; this medication can be habit-forming. If a dose is missed, take it immediately upon recollection. Complete the entire course of treatment, even with symptom improvement. Abrupt cessation should be avoided without consulting your doctor. Common side effects may include upper respiratory infection, increased hunger, elevated mood, trembling, vision blurring, dry mouth, lightheadedness, and drowsiness. Refrain from driving or tasks requiring concentration until the drug's effects are understood. Side effects are typically mild and resolve over time. Weight gain is possible; regular exercise and a balanced diet can help mitigate this. Report any unusual mood or behavioral shifts, new or worsening depression, or suicidal thoughts to your doctor immediately. Disclose all other medications to your doctor, as interactions can impact effectiveness or functionality. Inform your doctor of pregnancy, pregnancy plans, or breastfeeding.
Primary Ingredients of Vripreg-M Plus Tablet SR
No information provided. Please provide the text you wish me to rephrase.
Uses of Vripreg-M Plus Tablet SR
Managing neuropathic pain
Major Benefits of Vripreg-M Plus Tablet SR:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Vripreg-M Plus Tablet SR can be consumed with or without food, though consistent timing is recommended.
Common Side effects of Vripreg-M Plus Tablet SR:
- Sleepiness
- Dizziness
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Increased appetite
- Blurred vision
- Constipation
- Muscle cramp
- Edema (swelling)
- Erectile dysfunction
- Weight gain
- Balance disorder (loss of balance)
- Lethargy
- Vertigo
- Vomiting
- Headache
- Confusion
- Disorientation
- Abnormality of voluntary movements
How to use Vripreg-M Plus Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Vripreg-M Plus Tablet SR can be administered with or without food, though consistent timing is recommended.
How Vripreg-M Plus Tablet SR works:
Vripreg-M Plus SR tablets contain methylcobalamin and pregabalin, working synergistically to manage neuropathic pain. Methylcobalamin, a B vitamin, supports myelin production, protecting and repairing nerve fibers. Pregabalin, an alpha-2-delta ligand, reduces pain signals by modulating nerve cell calcium channels. This combination provides relief from the discomfort caused by nerve damage.
SAFETY ADVICE
AlcoholUNSAFE
Concomitant use of Vripreg-M Plus Tablet SR and alcohol may induce significant sleepiness.
PregnancyCONSULT YOUR DOCTOR
The use of Vripreg-M Plus Tablet SR during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescription. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Vripreg-M Plus Tablet likely poses a risk to breastfeeding infants. Available human data indicate potential transfer to breast milk with the possibility of infant harm.
DrivingUNSAFE
Driving should be avoided if you experience drowsiness, dizziness, visual disturbances, or reduced alertness after taking Vripreg-M Plus Tablet SR, as these are possible side effects.
KidneyCAUTION
Patients with impaired kidney function should exercise caution when using Vripreg-M Plus Tablet SR. Dosage modification may be necessary; physician consultation is recommended.
LiverSAFE IF PRESCRIBED
The use of Vripreg-M Plus Tablet SR in individuals with hepatic impairment is likely safe. Existing evidence indicates dose modification may be unnecessary; however, physician consultation is recommended.
What if you forget to take Vripreg-M Plus Tablet SR :
Should you forget a dose of Vripreg-M Plus Tablet SR, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Vripreg-M Plus Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Neuroscience |





